AstraZeneca Wins Bid To Limit Expert Testimony In Patent Infringement Dispute
NEWARK, N.J. — A federal judge granted AstraZeneca’s bid to restrict a defense expert’s testimony in litigation over patents covering its cancer drug Lynparza pending in a New Jersey federal court,...To view the full article, register now.
Already a subscriber? Click here to view full article